ENTITY
Moderna

Moderna (MRNA US)

109
Analysis
Health Care • United States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
bullish•Welltower
•25 Aug 2026 00:00

Options Weekly: Bears Hedge, Bulls Chase: A Split Market in Options

Options markets sent conflicting signals this week. Defensive put-buying surged across global financials, industrials, and high-momentum names. At...

Logo
100 Views
Share
bullish•Hang Seng Index
•22 Aug 2026 05:00

Hong Kong Single Stock Options Weekly Aug 17–21: Earnings, Biotech and Rising Option Volumes

Earnings-driven stock moves, rising option activity and renewed interest in Health Care shaped a stronger week across Hong Kong single stocks.

Logo
John Ley
110 Views
Share
•21 Aug 2026 09:22

CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!

CanSino Biologics (6185 HK)  shares surged on the back of Moderna (MRNA US)  breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...

Logo
167 Views
Share
•16 Aug 2023 08:55

China's Extremely Rare Policy to Attract Foreign Investment and the Signals Behind

Attracting foreign investment is commonplace and investors may not realize the importance,but new policy released by the State Council will bring...

Logo
584 Views
Share
•15 Dec 2022 14:11•Syndicated

CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations

Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...

Logo
611 Views
Share
x